Loading…
InflaRx N.V. is projected to rise to $2.63 by 2027, a +29% move from its current price of $2.05. IFRX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.95 | $2.05 | $2.15 | -0.08% |
| Jul 14 | $1.92 | $2.05 | $2.19 | -0.16% |
| Jul 15 | $1.89 | $2.05 | $2.22 | -0.24% |
| Jul 16 | $1.86 | $2.04 | $2.24 | -0.31% |
| Jul 17 | $1.84 | $2.04 | $2.27 | -0.39% |
| Jul 18 | $1.82 | $2.04 | $2.29 | -0.47% |
| Jul 19 | $1.80 | $2.04 | $2.31 | -0.55% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.80 | $2.04 | $2.31 | -0.55% |
| Week 2 | $1.70 | $2.03 | $2.42 | -1.10% |
| Week 3 | $1.63 | $2.02 | $2.50 | -1.64% |
| Week 4 | $1.56 | $2.01 | $2.57 | -2.18% |
| Week 5 | $1.51 | $1.99 | $2.63 | -2.72% |
| Week 6 | $1.46 | $1.98 | $2.69 | -3.25% |
| Week 7 | $1.42 | $1.97 | $2.74 | -3.79% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
InflaRx N.V. is a clinical-stage biopharmaceutical company that discovers and develops inhibitors using C5a technology in Germany and the United States. Its lead product candidate is vilobelimab, a first-in-class monoclonal anti-human complement factor C5a antibody, which is in Phase 3 clinical trial for the treatment for patients suffering from early septic organ dysfunction.
Izicopan, an oral, low molecular weight drug to target C5aR with high affinity and selectivity, has completed completing Phase 2a trials; IFX002, an advancement of vilobelimab technology, is in preclinical development for the treatment of chronic inflammatory indications. The company has co-development agreement with Staidson (Beijing) BioPharmaceuticals Co., Ltd.; Cell line sales agreement with Catalent Pharma Solutions LLC; Clinical Trial Collaboration Agreement with the U.S. DHHSs, Administration for Strategic Preparedness and Response (ASPR), BARDA and PPD Development, L.P., or PPD.
InflaRx N.V. was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. The company was founded in 2007 and is headquartered in Jena, Germany.
The stock trades at $2.11 per share. Its market capitalization is $310.79M and it ranks 3430. The price outlook shows a long-run path of rising averages, with 2026 average at $2.11, 2030 average at $6.39, and 2050 average at $43.78, accompanied by corresponding ROI figures of 0%, 202.8%, and 1974.8% respectively.
A major floor 59.4% below — a decisive break under it would weaken the trend.
The nearest floor, 22.0% below — buyers have tended to step in here.
The nearest ceiling, 17.1% above — a clean break opens room to run.
A major ceiling 37.4% above — clearing it would confirm fresh momentum.
Key IFRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IFRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.10 | Sell | $2.10 | Sell |
| MA 10 | $2.15 | Sell | $2.09 | Sell |
| MA 20 | $1.96 | Buy | $2.05 | Sell |
| MA 50 | $2.15 | Sell | $1.96 | Buy |
| MA 100 | $1.60 | Buy | $1.74 | Buy |
| MA 200 | $1.38 | Buy | $1.53 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.47 | Neutral |
| Stoch RSI (14) | 21.74 | Neutral |
| CCI (20) | 30.16 | Neutral |
| Williams %R (14) | -59.57 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 6.22 | Buy |
| Bollinger %B (20,2) | 0.60 | Neutral |
| Stochastic %K (14) | 40.43 | Neutral |
| TRIX (15) | 0.07 | Buy |
| Awesome (5,34) | 0.05 | Buy |
| Ultimate (7,14,28) | 40.43 | Neutral |
| Momentum (10) | 0.19 | Buy |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 2.05 | Sell |
| ADX (14) | 15.53 | Neutral |
| ATR (14) | 0.08 | Info |
The sentiment is BULLISH and the RSI(14) is 50. The 50-day simple moving average is $2.11 and the 200-day simple moving average is $1.37. The stock is framed by a support level at $1.60 and a resistance level at $2.74. The 30-day range runs from $1.50 to $2.97.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.825 | $2.05 | $2.64 | 0% | Neutral | |
| $1.96 | $2.63 | $3.82 | +29% | Bullish | |
| $2.19 | $3.11 | $4.77 | +52% | Bullish | |
| $2.83 | $4.19 | $6.72 | +104% | Bullish | |
| $3.97 | $6.11 | $10.18 | +198% | Bullish | |
| $3.95 | $6.32 | $10.86 | +208% | Bullish | |
| $3.84 | $6.35 | $11.23 | +210% | Bullish | |
| $4.32 | $7.39 | $13.41 | +261% | Bullish | |
| $4.34 | $7.68 | $14.25 | +274% | Bullish | |
| $5.80 | $10.58 | $20.06 | +416% | Bullish | |
| $7.05 | $14.94 | $30.92 | +629% | Bullish | |
| $19.45 | $43.23 | $99.43 | +20.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.825 | $2.05 | $2.42 | +0.00% |
| August 2026 | $1.55 | $1.87 | $2.33 | -8.93% |
| September 2026 | $1.57 | $1.91 | $2.43 | +2.19% |
| October 2026 | $1.64 | $2.01 | $2.60 | +5.58% |
| November 2026 | $1.60 | $1.98 | $2.60 | -1.49% |
| December 2026 | $1.59 | $1.99 | $2.64 | +0.26% |
Click any year to see its month-by-month IFRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, IFRX is projected to trade between $0.825 and $2.64, averaging $2.05 — a potential gain of 0% from today's $2.05. Price action looks broadly range-bound.
InflaRx N.V.'s 2027 outlook centres on $2.63, within a $1.96 to $3.82 range. That is up +29% on the projected 2026 average. That marks a +29% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, IFRX could reach as high as $4.77, with a base case around $3.11 and support toward $2.19 — roughly +52% from $2.05. Momentum favours further upside here.
Expect IFRX to range from $2.83 to $6.72 through 2029. The $4.19 average target implies a +104% move from current prices. That is up +35% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The IFRX price prediction for 2030 points to an average of $6.11 (low $3.97, high $10.18) — a potential gain of +198% on today's $2.05. Momentum favours further upside here.
In 2031, IFRX is projected to trade between $3.95 and $10.86, averaging $6.32 — a potential gain of +208% from today's $2.05. That is up +3% on the projected 2030 average. Buyers look set to stay in control over this stretch.
InflaRx N.V.'s 2032 outlook centres on $6.35, within a $3.84 to $11.23 range. That is up +1% on the projected 2031 average. That marks a +210% change versus current levels. Momentum favours further upside here.
By 2033, IFRX could reach as high as $13.41, with a base case around $7.39 and support toward $4.32 — roughly +261% from $2.05. Buyers look set to stay in control over this stretch.
Expect IFRX to range from $4.34 to $14.25 through 2034. The $7.68 average target implies a +274% move from current prices. That is up +4% on the projected 2033 average. Momentum favours further upside here.
The IFRX price prediction for 2035 points to an average of $10.58 (low $5.80, high $20.06) — a potential gain of +416% on today's $2.05. Buyers look set to stay in control over this stretch.
In 2040, IFRX is projected to trade between $7.05 and $30.92, averaging $14.94 — a potential gain of +629% from today's $2.05. That is up +41% on the projected 2035 average. Momentum favours further upside here.
InflaRx N.V.'s 2050 outlook centres on $43.23, within a $19.45 to $99.43 range. That is up +189% on the projected 2040 average. That marks a +20.1x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in IFRX today (≈ 487.804878 IFRX) could be worth
$21,088.35
+$20,088.35 (+2009%) by 2050 · US Dollar
Based on the average projected IFRX price of $43.23 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IFRXwould be worth at today's price.
$1,000 invested in IFRX on Jul 10, 2025 (≈ 1,117.31846 IFRX) would be worth
$2,290.5
+$1,290.5 (+129.1%) today · 2.29× · US Dollar
Based on a IFRX entry price of $0.895 vs. today's $2.05.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.24 | $915.18 | -8.5% |
| 1 month ago | $1.62 | $1,265.43 | +26.5% |
| 3 months ago | $1 | $2,050 | +105.0% |
| 6 months ago | $1.02 | $2,009.8 | +101.0% |
| 1 year ago | $0.895 | $2,290.5 | +129.1% |
| All time (5.0y) ago | $2.78 | $737.41 | -26.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IFRX forecast.
Our base-case forecast reaches $4.10 around 2029.
Implied market cap at $4.10: $603.9M
In 2026 the average price is forecast at $2.11 with a min of $0.825 and a max of $2.73 and a 0% ROI (sentiment NEUTRAL). From 2027 onward the forecast shows steady upside: 2027 average $2.69 (ROI 27.6%, BULLISH); 2028 average $3.15 (ROI 49.3%, BULLISH); 2029 average $4.35 (ROI 106.2%, BULLISH); 2030 average $6.39 (ROI 202.8%, BULLISH). By 2040 the average is $14.44 (ROI 584.3%, BULLISH) and by 2050 the average is $43.78 (ROI 1974.8%, BULLISH).
Tap a question to reveal the answer.
The forecast shows 2030 average $6.39 with a min $4.00 and max $10.99; ROI 202.8%; sentiment BULLISH.
The forecast path shows rising averages from 2026 to 2050 and bullish sentiment from 2027 onward, with 2030 average $6.39 and 2050 average $43.78 and ROI up to 1974.8%; these are estimates and not guarantees.
Yes. The 2030 max forecast is $10.99, indicating the possibility of exceeding $10 within the forecast horizon.
The current price is $2.11.
Market cap is $310.79M and rank is 3430.
InflaRx N.V. Community Discussion
0Share your InflaRx N.V. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.